Mucocutaneous Acyclovir Resistant HSV Infections FOSCAVIR is indicated for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. SAFETY AND EFFICACY OF FOSCAVIR HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER HSV INFECTIONS (e.g, RETINITIS, ENCEPHALITIS); CONGENITAL OR NEONATAL HSV DISEASE; OR HSV IN
In addition, ganciclovir should not be used for acyclovir-resistant HSV infections, because of cross-resistance. Ganciclovir and acyclovir share the same
the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients acyclovir-resistant hsv infections.
Drug Resistance: Resistance of HSV and VZV to acyclovir can Herpes Zoster Infections: ZOVIRAX is indicated for the acute treatment of herpes zoster.
For HSV that is resistant to acyclovir or ganciclovir, cidofovir and foscarnet are potential alternative treatments. These drugs do not require phosphorylation
by A Birkmann 2024 Cited by 18Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections HSV, treatment pritelivir; ○ = ACV resistant HSV, treatment
General Information ; Lab Name: HSV Acyclovir Drug Resistance ; Lab Code: HSVDR ; Epic Ordering: HSV Acyclovir Drug Resistance ; Description. HSV Type 1 and HSV
the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. According to IQVIA, US sales of Foscarnet
by KC Zachary Cited by 5action as acyclovir. Thus, HSV isolates resistant to acyclovir are also resistant to valacyclovir, famciclovir, and penciclovir. Resistant
Comments